Growth-suppressive effects of BPOZ and EGR2, two genes involved in the PTEN signaling pathway

M Unoki, Y Nakamura - Oncogene, 2001 - nature.com
Oncogene, 2001nature.com
Defects in PTEN, a tumor suppressor, have been found in cancers arising in a variety of
human tissues. To elucidate the tumor-suppressive function of this gene, we have been
analysing expression profiles of cancer cells after introduction of exogenous PTEN. Those
experiments identified 99 candidate genes that were transcriptionally transactivated. Among
them, we report here the further analyses of eight genes, EGR2/Krox-20, BPOZ, APS,
HCLS1/HS1, DUSP1/MKP1, NDRG1/Drg1/RTP, NFIL3/E4BP4, and a novel gene (PINK1 …
Abstract
Defects in PTEN, a tumor suppressor, have been found in cancers arising in a variety of human tissues. To elucidate the tumor-suppressive function of this gene, we have been analysing expression profiles of cancer cells after introduction of exogenous PTEN. Those experiments identified 99 candidate genes that were transcriptionally transactivated. Among them, we report here the further analyses of eight genes, EGR2/Krox-20, BPOZ, APS, HCLS1/HS1, DUSP1/MKP1, NDRG1/Drg1/RTP, NFIL3/E4BP4, and a novel gene (PINK1, PTEN-induced putative kinase). Expression of six of them (PINK1, EGR2, HCLS1, DUSP1, BPOZ, and NFIL3) was decreased in ovarian tumors compared with corresponding normal tissues. Colony-formation assays using plasmid clones designed to express each gene indicated that EGR2 and BPOZ were able to suppress growth of cancer cells significantly; in particular, cancer-cell lines stably expressing BPOZ grew more slowly than control cells containing mock vector. Flow cytometry suggested that over-expression of BPOZ inhibited progression of the cell cycle at the G 1/S transition. Anti-sense oligonucleotides for BPOZ or EGR2 effectively inhibited their expression, and cell growth was accelerated. Therefore both genes appear to be novel candidates as mediators of the PTEN growth-suppressive signaling pathway.
nature.com